Dr. Sarah M. Scott, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 500 W Broadway St, Missoula, MT 59802 Phone: 406-728-2539 Fax: 406-728-2709 |
Michael J Snyder, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 500 W Broadway St, Missoula, MT 59802 Phone: 406-728-2539 Fax: 406-728-2709 |
Stephen F Speckart, MD Internal Medicine - Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 500 West Broadway, Missoula, MT 59802 Phone: 406-728-2539 Fax: 406-728-2709 |
John M Trauscht, MD Internal Medicine - Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 500 West Broadway, Missoula, MT 59802 Phone: 406-728-2539 Fax: 406-728-2709 |
William C Nichols, MD Internal Medicine - Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 500 W Broadway, Missoula, MT 59802 Phone: 406-327-1918 Fax: 406-329-2937 |
Alan W Thomas, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 500 W Broadway St, Missoula, MT 59802 Phone: 406-728-2539 Fax: 406-728-2709 |
Patrick G Beatty, MD Internal Medicine - Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 500 W Broadway, Missoula, MT 59802 Phone: 406-728-2539 Fax: 406-728-2709 |
Linda M Ries, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 500 West Broadway, Missoula, MT 59802 Phone: 406-728-2539 Fax: 406-728-2709 |
News Archive
Dignity Health St. Mary's Medical Center has received the Distinguished Hospital Award for Clinical Excellenceâ„¢ from Healthgrades, the leading online resource for comprehensive information about physicians and hospitals. This is the second consecutive year St. Mary's has received this award, which recognizes St. Mary's as among the top five percent of more than 4,500 hospitals nationwide for clinical performance.
Cybex International, Inc., a leading manufacturer of premium exercise equipment, today reported results for its third quarter ended September 25, 2010. Net sales for the third quarter of 2010 were $29.2 million compared to $29.0 million for the corresponding 2009 period. The Company reported a net loss for the third quarter of 2010 of $15,000, or $0.00 per diluted share, compared to net income of $81,000, or $0.00 per diluted share, reported for the corresponding 2009 period.
High-resolution real-time images show in mice how nerves may be damaged during the earliest stages of multiple sclerosis. The results suggest that the critical step happens when fibrinogen, a blood-clotting protein, leaks into the central nervous system and activates immune cells called microglia.
Sudden unexpected infant death (SUID) is the leading cause of death among infants one month to one year of age, with more than 3,500 infants dying unexpectedly each year. Sudden Infant Death Syndrome (SIDS) is a major contributor.
› Verified 3 days ago